Daniel Lindholm

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Scott D. Solomon, John J.V. McMurray, Brian Claggett et al. · New England Journal of Medicine · 2022 · 2.4K citations · Full text

Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Valery L. Feigin, Melsew Dagne Abate, Yohannes Habtegiorgis Abate et al. · The Lancet Neurology · 2024 · 842 citations · Full text

National Burden, Cerebrovascular Disease, Health Studies +16

Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

Hazim Ababneh, Yohannes Habtegiorgis Abate, Cristiana Abbafati et al. · The Lancet · 2024 · 790 citations · Full text

Global Burden, Infectious Disease Epidemiology, Forecasting Analysis +13

Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction

Mikhail Kosiborod, Pardeep S. Jhund, Kieran F. Docherty et al. · Circulation · 2019 · 335 citations · Full text

Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the <scp>DELIVER</scp> trial

Scott D. Solomon, Rudolf A. de Boer, David L. DeMets et al. · European Journal of Heart Failure · 2021 · 307 citations · Full text